Who's Developing What in Drug Delivery?

Who's Developing What in Drug Delivery?
Espicom Healthcare Intelligence
October 20, 2006
816 Pages
Pub ID: ESPI1376719
Price: $995.00
Industry and commercial interest in drug delivery has been building steadily. The benefits to patients can be seen in improved compliance and medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes and bring new therapies to the market that would, previously, have been impossible.
A driving force for profits
The drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have seen significant attention from customers and investors alike, and merger and acquisition activity is notable.
Who's Developing What in Drug Delivery? is a new, fully updated management report (2nd edition published October 2006) that provides comprehensive analysis of more than 125 leading players in the drug delivery field.
Subjects covered in the report include:
Company Overview
Key Personnel
Key Milestones
Competitors and Competing Products
Products/Technologies
R&D and Research Strategy
Key Agreements and Alliances
Financial Data
Comprehensive Contact Details
Use this report to:
Assess potential technology partners
Evaluate competitor's performance
Profile competing products
Understand research trends
Identify development opportunities in the market
Know who is working with who, and on what
Additional Information
Leading drug delivery companies analysed:
Access Pharmaceutical
Acusphere
Acrux
Advanced Drug Delivery Technologies
Alizyme
Alkermes
AlphaRx
AlphaVax
Altea Therapeutics
ALZA Corporation
Andrx Corporation
Antares Pharma
AP Pharma
Aradigm Corporation
Baxa Corporation
Baxter International
Bentley Pharmaceuticals
Bespak
BioDelivery Sciences International
Bioject Medical Technologies
BioProgress
BioSante Pharmaceuticals
Biovail Corporation
Bradley Pharmaceuticals
Camurus
Cardinal Health Alaris Products
Cellegy Pharmaceuticals
Cephalon
Cipher Pharmaceuticals
Columbia Laboratories
Curlin Medical
CyDex
DebioPharm
Delcath Systems
Delsite Biotechnologies
DepoMed
Diatos
Direct Haler
DOR Biopharma
Durect Corporation
DUSA Pharmaceutical
Eiffel Technologies Elite Pharmaceuticals
Emisphere Technologies
Encap Drug Delivery
Endo Pharmaceuticals
Endovasc
Enpath Medical
Enzon
Ethypharm
Eurand
Evit Labs
Expression Genetics
Fertin Pharma
Flamel Technologies
FzioMed
Generex Biotechnology Corporation
Glycologic
Hospira
Idea
Impax Laboratories
INEX Pharmaceuticals
Innovata Biomed
Inovio Biomedical
InSite Vision
Intransal Technologies
Iomai Corporation
Iomed
Kos Pharmaceuticals
KV Pharmaceuticals
Labopharm
LAB International
LAM Pharmaceutical
Corporation
Lavipharm Corporation
Light Sciences Corporation
Lipid Technologies Provider
Lyfjathroun Biopharmaceuticals
MacroChem Corporation
MacroMed
MaxCyte
McKinley Medical
MedImmune
MicroCHIPS
Milestone Scientific Miravant Medical Technologies
Nanotherapeutics
Nastech Pharmaceutical Company
Nektar Therapeutics
NeoPharm
Neurotech
NexMed
Norwood Abbey
NovaDel Pharma
Novagli Pharma
Novavax
Noven Pharmaceuticals
Oakwood Laboratories
OctoPlus
Oriel Therapeutics
Otsuka Phamaceuticals
Penwest Pharmaceuticals
Phoqus Group
PhotoCure
Point Biomedical Corporation
Psivida
Respironics
Scolr Pharma
Shire
Skinvisible
SkyePharma
Sontra Medical Corporation
Sonus Pharmaceuticals
Spherics
Supratek Pharma
Synt:em
Syntonix Pharmaceuticals
The Medical House
TransPharma Medical
Valentis
Valera Pharmaceuticals
Vectura
Ventaira
Vivier Pharma
Vivus
Comments: 0
Votes:16